CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.

作者: Patrycja Koszałka , Monika Gołuńska , Marcin Stanisławowski , Aleksandra Urban , Grzegorz Stasiłojć

DOI: 10.1016/J.BIOCEL.2015.10.003

关键词:

摘要: Ecto-5'-nucleotidase (CD73), an enzyme providing interstitial adenosine, mediates diverse physiological and pathological responses. In tumor progression, it has primarily immunosuppressive role but is also thought to regulate neovascularization. However, the latter still in debate. When B16F10 melanoma was subcutaneously injected into CD73 knockout mice, changes vasculature were not always observed. we demonstrated earlier that growth vascularization of mice depend on low presence cells. To further analyze vascularization, compared right flank wild-type lacking host only, with cell either inhibited AOPCP (adenosine α,β-methylene 5'-diphosphate) or permanently knocked down through genetic modification. We report here both inhibition knockdown alone. MAP-kinase signaling pathway activation decreased more strongly stable knockdown. There a significant reduction angiogenic blood microvessels as observed by anti-VEGFR2 staining. Stable reduced endothelial proliferation measured anti-CD105 only chemical significantly augmented intratumoral microvessel density induced knockout. Such when due much slower oxygen demand indicated expression Bad, hypoxia marker. Decreased activity led factors, including VEGF bFGF partially reversed tumors treated AOPCP. Both macrophage infiltration microenvironment changes, thereby influencing MI MII polarization. Additionally, important metastasis formation adenosine-independent attachment endothelium. conclude even undeniable regulation many aspects angiogenesis. thus viable target anti-angiogenic therapy.

参考文章(53)
P R Carroll, N Weidner, J Flax, W Blumenfeld, J Folkman, Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology. ,vol. 143, pp. 401- 409 ,(1993)
Letícia Scussel Bergamin, Elizandra Braganhol, Fabrício Figueiró, Emerson André Casali, Rafael Fernandes Zanin, Jean Sévigny, Ana Maria Oliveira Battastini, Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma‐conditioned medium Journal of Cellular Biochemistry. ,vol. 116, pp. 721- 729 ,(2015) , 10.1002/JCB.25018
Jun Zhang, Ji Cao, Shenglin Ma, Rong Dong, Wen Meng, Meidan Ying, Qinjie Weng, Zibo Chen, Jian Ma, Qingxia Fang, Qiaojun He, Bo Yang, Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling. Oncotarget. ,vol. 5, pp. 9664- 9677 ,(2014) , 10.18632/ONCOTARGET.1856
P. Fishman, S. Bar-Yehuda, M. Synowitz, J.D. Powell, K.N. Klotz, S. Gessi, P.A. Borea, Adenosine Receptors and Cancer Adenosine Receptors in Health and Disease. ,vol. 193, pp. 399- 441 ,(2009) , 10.1007/978-3-540-89615-9_14
Hoyer Lc, Dragsten P, Sela Ba, Hart Ir, Fidler Ij, Bucana Cd, McLellan Wl, Raz A, Cell Surface Properties of B16 Melanoma Variants with Differing Metastatic Potential Cancer Research. ,vol. 40, pp. 1645- 1651 ,(1980)
Stefania Merighi, Carolina Simioni, Stefania Gessi, Katia Varani, Prisco Mirandola, Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Pier Andrea Borea, None, A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin Neoplasia. ,vol. 11, pp. 1064- 1073 ,(2009) , 10.1593/NEO.09768
Bertrand Allard, Martin Turcotte, Kathleen Spring, Sandra Pommey, Isabelle Royal, John Stagg, Anti-CD73 therapy impairs tumor angiogenesis. International Journal of Cancer. ,vol. 134, pp. 1466- 1473 ,(2014) , 10.1002/IJC.28456
Friedhelm Schroeder, Jack M. Gardiner, Membrane Lipids and Enzymes of Cultured High- and Low-Metastatic B16 Melanoma Variants Cancer Research. ,vol. 44, pp. 3262- 3269 ,(1984)
Stefania Gessi, Stefania Merighi, Katia Varani, Edward Leung, Stephen Mac Lennan, Pier Andrea Borea, None, The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacology & Therapeutics. ,vol. 117, pp. 123- 140 ,(2008) , 10.1016/J.PHARMTHERA.2007.09.002